Le Lézard
Classified in: Mining industry, Health, Science and technology
Subjects: SVY, CSR, LGB, DEI, ESG

Avantor® Releases 2024 Science for Goodness Sustainability Report

Achieves 2025 Greenhouse Gas Emission reduction goals two years ahead of schedule

RADNOR, Pa., June 18, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, released its 2024 Sustainability Report today. The report highlights the meaningful progress Avantor made in 2023 against four Science for Goodness sustainability pillars: People & Culture, Innovation & Environment, Community Engagement, and Governance & Integrity.

"Our Science for Goodness platform is integral to our business strategy and to the value that we provide to our stakeholders," said Michael Stubblefield, President and CEO of Avantor. "We are pleased with the progress we have made and remain committed to creating a better, healthier world." 

Highlights from Avantor's 2024 Sustainability Report include:

People & Culture: Avantor earned a top score on the Human Rights Campaign's 2023 Corporate Equality Index, a national benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality. As part of our efforts to promote inclusion and respect in the workplace, one-quarter of associates participated in Associate-Centric Teams (ACTs) which provide our associates with opportunities to elevate their voices and deepen their understanding of others' experiences and perspectives. 

Innovation & Environment: Avantor achieved its 2025 emissions reduction target two years ahead of schedule, reducing operational greenhouse gas emissions by 16.7 percent from 2019 to 2023. Having achieved this critical milestone, we have now set new targets for 2030 to reduce  Scope 1 and 2 emissions by 50 percent from a 2020 baseline and reduce Scope 3 emissions by 25 percent from a 2020 baseline.

Community Engagement: In 2023, the Avantor Foundation awarded more than $1.2 million in grants to provide healthcare services and STEM education opportunities to underserved communities where Avantor has a presence. We also empowered our associates to support organizations worldwide that bring our mission to life, and in 2023, they contributed nearly 10,000 volunteer hours.

Governance & Integrity: Avantor launched our Responsible Supplier Program in 2023, aiming to improve supplier performance across four priority areas: climate change, human rights, resource circularity and nature conservation. Building on our strong supplier relationships, some of which have been in place for more than 20 years, Avantor enrolled more than 340 suppliers, representing 45 percent of our supplier spend, into the program in 2023.

For more information regarding how Avantor is embedding sustainability across its businesses and progressing programming, and to view a copy of the full 2024 report, please visit our web site.

About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to customers in the life sciences and advanced technology industries. From discovery to delivery, we work side-by-side with scientists around the world to enable breakthroughs in medicine, healthcare, and technology at scale. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.

Global Media Contact
Emily Collins
Vice President, External Communications
[email protected] 

Investor Relations Contact
Christina Jones
Vice President, Investor Relations
[email protected]

SOURCE Avantor and Financial News

These press releases may also interest you

at 03:09
Ricovr Healthcare is proud to announce that it has been awarded a competitive Small Business Innovation Research grant from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) for the development of its...

at 03:05
Saphetor SA, the creators of the global human genetics community VarSome, today announced European CE mark approval of the VarSome Clinical platform for the automated variant discovery, annotation, and interpretation of Next Generation Sequencing...

at 03:05
PK MED, a French biotech company, privately owned, and established in 2019 by Truffle Capital, announced it has secured a non-dilutive DeepTech financing of ? 1.5 million from Bpifrance. The funding will accelerate the company's project PKM-02, an...

at 03:00
Viewpoint, the acclaimed educational program hosted by Dennis Quaid, is excited to announce the development of a new episode in collaboration with Positive Approach to Care. This upcoming segment will focus on innovative approaches to cognitive...

at 03:00
CS Analytical Laboratory, the world's only cGMP, FDA-registered and inspected contract laboratory exclusively designed and dedicated to container testing for the pharmaceutical, biotechnology, and medical device...

at 03:00
New cognition/function and extensive plasma biomarker results of T3D-959 treatment from the Phase 2 PIONEER trial, in a modified intent-to treat population of mild to moderate Alzheimer's patients will be presented at the upcoming Alzheimer's...

News published on and distributed by: